Evidence map›Paper›PMID 25411200›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.

Subhash Gaddipati, Kathleen Estrada, Pushpa Rao, Andrew David Jerome, Susmit Suvas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Foxp3Experimental eye research · 2024
    Article
  4. Role of IL-27 in HSV-1-Induced Herpetic Stromal Keratitis.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. IL-2 complex treatment amplifies CD8Microbes and infection · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Subhash GaddipatiDepartment of Biological Sciences, Oakland University, Rochester, MI 48309; Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201; Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201; and.
Kathleen EstradaDepartment of Biological Sciences, Oakland University, Rochester, MI 48309; Michigan State University College of Human Medicine, East Lansing, MI 48824.
Pushpa RaoDepartment of Biological Sciences, Oakland University, Rochester, MI 48309; Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201; Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201; and.
Andrew David JeromeDepartment of Biological Sciences, Oakland University, Rochester, MI 48309; Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201; Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201; and.
Susmit SuvasDepartment of Biological Sciences, Oakland University, Rochester, MI 48309; Department of Ophthalmology, Wayne State University School of Medicine, Detroit, MI 48201; Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201; and ssuvas@med.wayne.edu.
Wayne State University · USOakland University · US

Funding

Corneal neuropeptides and herpetic stromal keratitisR01EY022417 · NEI · WAYNE STATE UNIVERSITY · PI SUVAS, SUSMIT · 2013 to 2017
$1.9M
NEI NIH HHS EY022417NEI NIH HHS R01 EY022417
6 · The paper itself

Abstract

The IL-2/anti-IL-2 Ab immunocomplex has recently been shown to expand the naturally occurring pool of CD4(+)Foxp3(+) regulatory T cells (Tregs). In this study, we show that administration of the IL-2/anti-IL-2 Ab immunocomplex to C57BL/6 mice, prior to corneal HSV-1 infection, significantly increased the pool of Foxp3(+) Tregs when measured at early time points postinfection. Increased numbers of Foxp3(+) Tregs on days 2 and 4 postinfection resulted in a marked reduction in the development of severe herpetic stromal keratitis (HSK). When compared with corneas from the control group, corneas from the immunocomplex-treated group showed a significant reduction in the amount of infectious virus on day 2 but not on day 4 postinfection. Reduced viral load was associated with a 2-fold increase in NK cell numbers in corneas from the immunocomplex-treated group of mice. Moreover, a dramatic reduction in the influx of CD4 T cells in inflamed corneas was determined on days 7 and 16 postinfection in the immunocomplex-treated group of infected mice. Immunocomplex treatment given on days 5, 6, and 7 postinfection significantly increased Foxp3(+) Tregs in draining lymph nodes and in the spleen but failed to reduce the severity of HSK. In terms of the influx of CD4 T cells and granulocytes into inflamed corneas, no significant differences were noted between both groups of mice on day 16 postinfection. Our findings demonstrate that increasing Foxp3(+) Tregs early but not late postinfection in secondary lymphoid tissues is more efficacious in controlling the severity of HSK.

Indexed as

AnimalsAntibodies, MonoclonalCell MovementCorneaDisease ProgressionFemaleForkhead Transcription FactorsGranulocytesHerpesvirus 1, HumanImmunotherapyInterferon-gammaInterleukin-2Keratitis, HerpeticLymph NodesMiceMice, Inbred C57BLAntibodies, MonoclonalForkhead Transcription FactorsFoxp3 protein, mouseInterferon-gammaInterleukin-2

Identifiers

PMID25411200
PMCPMC4272922
OpenAlexW2149477225

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.